We have identified and partially sequenced a soluble factor, myotrophin, from spontaneously hypertensive rat hearts and hypertrophic human hearts that enhances myocyte protein synthesis and stimulates myocardial cell growth. Our studies suggest that myotrophin may be a biochemical link between hemodynamic stress and myocardial cellular hypertrophy. When rat neonatal cardiac myocytes maintained in culture were incubated with myotrophin for 30 minutes, they showed a marked increase in c-myc, c-fos, and c-jun messenger RNA levels. Cardiac myocytes treated for 24 hours with myotrophin showed a fourfold increase in connexin 43 (gap junction protein), a sixfold increase in atrial natriuretic factor, a threefold increase in skeletal a-actin, and a threefold increase in total myosin transcript levels. Studies on myosin isoforms showed a selective increase in the /3-myosin heavy chain transcript levels but no reciprocal decrease in or-myosin heavy chain transcript levels. Our data suggested that myotrophin appears to be a primary modulator for myocardial cell growth and differentiation and may play an important role in the pathogenesis of cardiac hypertrophy. Myotrophin may be involved in the upregulation of myofibrillar protein and the activation of cardiac gene transcription during growth and hypertrophy of the myocardium, and the induction of early response gene expression may be linked to this response. (Hypertension 1993;21:142-148) KEY WORDS • myotrophin • hypertrophy • RNA, messenger • actins • natriuretic peptides, atrial T he mechanisms involved in the development of myocardial hypertrophy and its regression cannot be fully explained by blood pressure control alone. Studies from our laboratory have provided evidence that factors other than blood pressure control play an important role in the initiation of myocardial hypertrophy in hypertension.
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We have identified and partially sequenced a soluble factor, myotrophin, from spontaneously hypertensive rat hearts and hypertrophic human hearts that enhances myocyte protein synthesis and stimulates myocardial cell growth. Our studies suggest that myotrophin may be a biochemical link between hemodynamic stress and myocardial cellular hypertrophy. When rat neonatal cardiac myocytes maintained in culture were incubated with myotrophin for 30 minutes, they showed a marked increase in c-myc, c-fos, and c-jun messenger RNA levels. Cardiac myocytes treated for 24 hours with myotrophin showed a fourfold increase in connexin 43 (gap junction protein), a sixfold increase in atrial natriuretic factor, a threefold increase in skeletal a-actin, and a threefold increase in total myosin transcript levels. Studies on myosin isoforms showed a selective increase in the /3-myosin heavy chain transcript levels but no reciprocal decrease in or-myosin heavy chain transcript levels. Our data suggested that myotrophin appears to be a primary modulator for myocardial cell growth and differentiation and may play an important role in the pathogenesis of cardiac hypertrophy. Myotrophin may be involved in the upregulation of myofibrillar protein and the activation of cardiac gene transcription during growth and hypertrophy of the myocardium, and the induction of early response gene expression may be linked to this response. T he mechanisms involved in the development of myocardial hypertrophy and its regression cannot be fully explained by blood pressure control alone. Studies from our laboratory have provided evidence that factors other than blood pressure control play an important role in the initiation of myocardial hypertrophy in hypertension. 1 Recently we have shown the existence of a factor, "myotrophin," in the myocardium of spontaneously hypertensive rats (SHR) and hypertrophied human hearts that enhances protein synthesis in myocytes in vitro. 2 We have purified this factor to homogeneity and partially sequenced it. An important property of myotrophin is that when added to neonatal rat myocytes maintained in culture, it accelerates myocardial cell growth and increases the number of sarcomeres and gap junction formation. 2 Myoirophin's mechanism of action in modulating myocyte growth is not known. It has been suggested that the jun protein and the products of the c-myc and c-fos genes may be essential to the ability of growth factors to regulate gene transcription. 3 Just as the fos and jun proteins, 4 the myc protein binds to DNA and directly stimulates gene transcription. 5 Several lines of evidence suggest that the 10 The rat myosin heavy chain cDNA was obtained from Dr. V. Mahdavi, Harvard University, Boston, Mass." The 18s ribosomal (rRNA) 12 oligomer, skeletal a-actin, 13 and a-and /3-myosin heavy chain 13 oligomers were synthesized in the Department of Molecular Biology, The Cleveland Clinic Foundation, Cleveland, Ohio. For the 18s rRNA oligomer we used a 24-base oligonucleotide (5'-ACGG-TATCTGATCGTCTTCGAACC-3') complementary to rat 18s rRNA. 12 We used oligonucleotide probes similar to that reported by Gustafson et al 13 for the a-(5'-TTGTGGGATAGCAACAGCGA-3') and 0-(5'-GGTCTCAGGGCTTCACAGGC-3') myosin heavy chain transcripts complementary to the rat cDNA clones. The probe for a-skeletal actin was 5'-GCAAC-CAT AGCACGATGGTC-3' complementary to the rat cDNA. 13 PMA (4/3-phorbol 12-myristate 13-acetate) was dissolved in dimethyl formamide as 10~2 M stock solution and further dissolved in water. The final concentration of the solvent in the cell suspensions did not exceed 0.001% and was added at an equal concentration in appropriate control wells.
Procedures
Source of myotrophin. Immunoaffinity-purified myotrophin was used for this series of experiments. Specific antibodies to myotrophin (immunoglobulin G [IgG] fraction) 14 were covalently coupled to an insoluble cellulose matrix. Partially purified myotrophin, G-75 fraction, 2 was applied to this column of immobilized antibody. Contaminating protein molecules were washed off, and the bound antigen was then eluted from the immobilized antibody by lowering the pH of the buffer sufficiently to disrupt the antigen-antibody complex but not the covalent antibody-matrix linkage. 15 The homogeneity of the immunopurified myotrophin was confirmed by high-performance liquid chromatography (HPLC) analysis and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). On silver staining SDS-PAGE showed only one protein band, which had a molecular weight of 12,000 d (Figure 1) . Myotrophin appeared as a single protein peak on HPLC when immunopurified material was applied on a Vydac C 18 column and eluted using a linear gradient of acetonitrile from 0% to 60% (unpublished observations). 2 Briefly, ventricles from the hearts of 3-day-old rat pups were harvested and suspended in a small amount of Joklik's media. The tissue was minced and incubated in the presence of collagenase for 20 minutes (84 units/ml; Worthington Biochemicals) in a water bath at 37°C. The released detached cells were aspirated with a pipette and transferred into a 50-ml tube. The residual tissue was redigested several times until all the cells were detached. The cells were centrifuged at 300g for 10 minutes. The heavier myocytes settled at the bottom of the tube, and the nonmyocyte fraction remained in the supernatant. The myocytes were suspended in DVF 12 media and centrifuged again at 300g. The myocytes were suspended in DVF 12 media containing 5% (wt/vol) fetal bovine serum. The cells were plated in a density of 2xlO 6 /35 mm well, and about 10 6 cells attached to the plate. The plates were kept in an incubator at 37°C in a 95% O 2 -5% CO 2 atmosphere. On the second day the media were removed, and fresh medium was added that was supplemented with fetuine (10 /xg/ml), 2.5 ml transferrin (1 /xg/ml), and 50 ^,1 hydrocortisone. On the third day, the effect of myotrophin on myocyte protein synthesis was studied as described below.
Effect of myotrophin on protein synthesis. On the third day, the media were removed, and fresh medium without the fetal bovine serum, fetuine, transferrin, and hydro-cortisone was added. [ 3 H]Leucine (272.2 xlO 6 dpm/nmol; 5 /j,Ci/ml) was added to each well, and the cells were incubated in the presence or absence of the myotrophin for 24 hours at 37°C. Twenty nanograms myotrophin (10 ng/ml, i.e., approximately 0.84 pM) was added per well in 2 ml DVF 12 media. At the end of the incubation period the medium was aspirated, and 1 ml SDS (0.1%)/NaOH (IN) solution was added. After the cells were allowed to stand for 30 minutes with occasional shaking, 1 ml bovine serum albumin (0.5 mg/ml) was added. One milliliter 20% trichloroacetic acid was added to each well. All the plates were kept in a cold room at 4°C for 30 minutes. The proteins from each cell were collected into individual filter paper in a cell harvester (Brandel, Gaithersburg, Md.), and 5% trichloroacetic acid was used to wash them exhaustively until they were free of unincorporated radioactive isotope; they were then air dried for 2 hours and counted in a Beckman /3-scintillation counter. Data are expressed as disintegratons per minute per microgram DNA.
RNA extraction. Total RNA was extracted from neonatal cardiac myocytes using the method described by Chomczynski and Sacchi. 16 Yields were quantitated by the absorbance at 260 nm. The RNA yield was about 10 jtg/35-mm well, with each well containing about 10 6 cells. The ratio of the absorbance at 260/280 was more than 1.9 for all the samples. Integrity of the RNA was ascertained by the appearance of the 18s and 28s rRNA bands after agarose formaldehyde gel electrophoresis 17 and ethidium bromide staining. Poly (A)+ RNA was extracted from total RNA using an Oligo(dT) column. 18 Effect of myotrophin on early response genes. On the third day cardiac myocytes were treated with myotrophin for 30 minutes to evaluate its effects on the expression of the proto-oncogenes c-myc, c-fos, and c-jun. Myocyte cultures (two plates of six wells each, 10 6 cells/well) received one of three treatments. Myotrophin-treated cells received 10 ng/ml myotrophin as described above. Positive control cultures were treated with 10" 7 PMA. Negative control cultures received DVF 12 media containing a volume of phosphate-buffered saline-0.001% dimethyl formamide equal to the volume used in positive control cultures. Experiments were done on at least two different sets of myocytes cultured on different days. Transcript levels were then assessed by Northern blot analysis. To assess the level of the expression of various proto-oncogene messenger RNAs (mRNAs), 2 ju,g Poly (A)+ RNA was electrophoresed in each sample on 1% agarose-formaldehyde gels. Oligonucleotides for c-myc, c-fos, and c-jun were labeled at the 5' end to a specific activity of 10 8 cpm//xg DNA with T4 polynucleotide kinase. All hybridizations were performed at 42°C. Final washes were as follows: c-myc, c-fos, and c-jun, each at 0.2 x standard saline citrate (SSC), 0.1% SDS, 58°C ( l x SSC=0.15 M sodium chloride/0.015 M sodium citrate, pH 7). After hybridization to c-myc, c-fos, and c-jun probes and autoradiographic exposure, the filters were stripped and rehybridized to the GAPDH probe. The blots were exposed on x-ray films with intensifying screens for 1-3 days at -70°C. Relative amounts of each mRNA were determined by video densitometry (Image Analyzer, Fotodyne Inc, New Berlin, Wis.) in the linear response range of the x-ray films. The densitometric scores of specific mRNAs were "normalized" by that of GAPDH mRNA, which encodes a constitutively expressed glycolytic enzyme, as an internal control.
Effect of myotrophin on markers of hypertrophy. To study the effect on ANF, skeletal a-actin, myosin heavy chain, and connexin 43 mRNA levels, neonatal myocytes were treated with myotrophin for 24 hours. As a control, RNA was extracted from two six-well plates (35- mm well diameter, approximately 10 6 cells/well) treated with phosphatebuffered saline; and two similar six-well plates treated with 10 ng/ml myotrophin in phosphate-buffered saline were used to study the effect of myotrophin. Experiments were done on at least two different sets of myocytes cultured on different days. Fifteen micrograms total RNA from the two sets of controls and the myotrophin-treated neonatal cardiac myocytes were run on a 1% agaroseformaldehyde gel, blotted onto a nylon membrane and hybridized to radiolabeled probes. The cDNA encoding connexin 43 and the total myosin heavy chain were nick translated to a specific activity of 2-4 x 10 9 cpm/jAg DNA. Oligonucleotides were labeled at the 5' end to a specific activity of 10 8 cpm/jig DNA with T4 polynucleotide kinase. All hybridizations were performed at 42°C. The final washes were as follows: connexin 43 at 0.2 x SSC, 0.1% SDS, 45°C; total myosin heavy chain at 0.2x SSC, 0.1% SDS, 50°C; o-skeletal actin at 0.1 x SSC, 0.1% SDS, 50°C; a-myosin heavy chain at 2x SSC, 0.1% SDS, 60°C; /3-myosin heavy chain at 2x SSC, 0.1% SDS, 60°C; ANF at l x SSC, 0.1% SDS, 60°C; GAPDH at 0.2x SSC, 0.1% SDS, 56°C; and 18s rRNA at 0.1 x SSC, 0.1% SDS, 66°C. After hybridization to ANF, a-skeletal actin, myosin or gap junction probes, and autoradiographic exposure, the filters were stripped and rehybridized to the GAPDH probe, the 18s rRNA probe, or both.
The blots were exposed on x-ray films with intensifying screens for 1-3 days at -70°C. Autoradiograms were quantitated as described above and normalized using GAPDH and 18s rRNA.
Separation of myosin isoforms. Total myosin was extracted from the neonatal cells and separated by SDS-PAGE by the procedures described previously. 19 For each group, the control and neonatal cells treated with myotrophin (n = 16 wells, 35-mm diameter) were frozen immediately after the incubation period. The cells were scraped, and myosin was extracted from the cells using the method described by Hoh et al. 20 The myosin was separated by SDS-PAGE using nondenaturing conditions and was quantified by scanning densitometer (Helena Laboratories).
Statistical Analysis
Each group in each experiment consisted of 2-4 culture plates (6 wells/plate). For protein synthesis, values for treated groups were normalized to the control value (vehicle treated) in each experiment. For analysis of transcript levels, values were expressed relative to control values. Results are expressed as mean±SEM. The difference between two groups was tested by an unpaired Student's / test. Differences among more than two groups were tested by analysis of variance for multiple sample comparison. Statistical significance was defined as/?<0.05.
Results

Effect of Myotrophin on Protein Synthesis
When immunopurified myotrophin was added to neonatal cardiac myocytes and incubated for 24 hours, a (Figure 2 ). This rate was similar to that previously reported. 2 The stimulation of protein synthesis can be blocked by pretreatment of the cardiomyocyte with polyclonal antibodies raised against myotrophin ( Figure  2 ). The specificity of the antibody for myotrophin was confirmed by Western blot analysis. 14 
Effect of Myotrophin on Early Response Gene Transcript Levels
The oligomer probe for c-myc hybridized to a 2.4 kb mRNA. We observed a marked increase in c-myc transcript levels when neonatal myocytes were treated with myotrophin. Neonatal cardiac myocytes treated with 10~7 M PMA also showed a marked induction of c-myc mRNA. The oligomer probe for c-fos hybridized to a 2.2 kb probe. No c-fos mRNA was detected in the control neonatal cardiac myocytes. However, both myotrophin and PMA markedly induced the transcript level of c-fos in neonatal cardiac myocytes. The probe for c-jun hybridized with mRNA of two distinct sizes (3.2 and 2.7 kb). No detectable signal was seen in the control cardiac myocytes. Both myotrophin and PMA markedly induced the transcript levels of c-jun. The amount of RNA loaded in each lane was corrected by normalizing to the level of GAPDH expression (Figures 3 and 7) . 
Poly (A) + RNA (2 ng) was run on a formaldehyde-agarose gel and transferred to a nylon membrane. The same filter was hybridized with specific oligonucleotide probes for c-myc (translated sequences of exon 2), c-fos (derived from the first exon), and c-jun (N-terminus ofmurine c-jun). The filter was dehybridized and rehybridized with a probe for glyceraldehyde 3-phosphate dehydrogenase (GAPDH). A composite of the autoradiograms is presented.
Effect of Myotrophin on At rial Natriuretic Factor and Skeletal a-Actin Transcript Levels
An oligomer probe was used to detect the amount of ANF mRNA in cardiac myocytes, which detected a 0.9 kb mRNA. Myotrophin-treated neonatal cardiac myocytes showed a sixfold increase in ANF mRNA levels compared with that in the control cells. A probe specific for skeletal a-actin hybridized to a 1.9 kb mRNA. Myotrophin-treated cells showed a threefold increase in skeletal a-actin mRNA levels. The amount of RNA loaded in each lane was normalized to the levels of GAPDH mRNA. Value for individual mRNA was divided by the corresponding GAPDH mRNA for that sample. Data is summarized in Figures 4 and 7 .
Effect of Myotrophin on Gap Junction and Myosin Transcript Levels
From Northern blot analyses of total RNA from treated and untreated cells (Figure 4) we observed a 425% increase in the level of connexin transcripts. With ultrastructural studies we had also previously observed an increase in the number of sarcomeres in myotrophintreated cells. To assess the effect of myotrophin treatment on transcripts encoding sarcomeric proteins, we examined the level of transcripts encoding total myosin heavy chains and the a-and /3-myosin heavy chain isoforms. Our data showed that myotrophin treatment produced a threefold increase in the level of total myosin heavy chain transcript levels. The enhancement of myosin heavy chain transcript levels was specific for /3-myosin heavy chain transcripts only as the j3-myosin heavy chain transcript levels increased 303%, whereas 1 1. a-myosin heavy chain transcript levels were unchanged ( Figures 5, 6 , and 7).
EFFECT OF MYOTROPHIN ON CONNEXIN
Effect of Myotrophin on Myosin Isoform Protein Levels
When total myosin was extracted and separated by SDS-PAGE, the three distinct bands obtained from the control group had the following distribution: V, (oca) 74.3±1.9%; V 2 (a/3) 17.2±1.3%; V 3 (/3/3) 8.5±0.5%. In the myotrophin-treated group a significant change (n=3, p<0.05) in distribution pattern was noted: V, (aa) 56.8±1.2%; V 2 (a/3) 24.5±1.4%; V 3 (j8j3) 18.7±0.9%. This enhanced percentage of V 3 forms is consistent with the increase in /3-myosin heavy chain transcript levels that we observed.
Discussion
We have shown that myotrophin induces the mRNA levels of early response genes such as c-myc, c-fos, and c-jun in cultured rat neonatal cardiac myocytes. Myotrophin also increases the mRNA levels of ANF, /3-myosin heavy chain, skeletal a-actin, and connexin 43. A spectrum of particular genes show altered expression when the myocardium undergoes hypertrophic growth. 21 Besides the induction of proto-oncogene expression, alterations also occur in genes that affect cardiac function. 22 Various workers have previously described increased ANF gene expression in rat ventricular myocardium during experimental hypertension. 6 ANF is released by the overloaded atria and may improve the loading conditions of the cardiac pump by its vasorelaxant, diuretic, and natriuretic properties. 7 It has been shown that ventricular myocardium can also produce ANF, 23 and that during chronic pressure and volume overload, 24 as well as in SHR, 25 ANF mRNA and immunoreactive ANF increase in the left ventricle. In this study we observed a 600% increase in ANF mRNA levels when cardiac myocytes were treated with myotrophin. Numerous studies have suggested that the hypertrophic response may include the reappearance, in adult tissue, of contractile protein isoforms characteristic of earlier development stages. 89 The use of specific recombinant DNA probes has confirmed that the genes for these fetal and neonatal isoforms are re-expressed, including the gene for skeletal a-actin. 26 -27 Neonatal cardiac myocytes treated with myotrophin displayed a 300% increase in skeletal a-actin mRNA levels over control.
Myosin is a major component of the contractile apparatus of the heart. In the heart, myosin heavy chain proteins can be identified in nondenaturing gels as three different isozymic dimer forms: V, (aa), V 2 (a/3), and V 3 (/3/3), as assigned according to their electrophoretic mobility.
18 V! and V 3 are homodimers of the proteins encoded by the a-myosin heavy chain and /3-myosin heavy chain genes, respectively; V 2 is a heterodimer of these two related but different proteins. These proteins differ in amino acid sequence and in their enzymatic activities; V, has high ATPase activity, whereas that of V 3 is lower. 28 In the heart, the functional consequences of these two myosin heavy chain forms arise from the differing rates of velocity of shortening that can occur in muscle containing different proportions of these myosin heavy chain forms. Thus, heart muscle rich in the high ATPase form V, has a much greater maximum rate of contraction than does myocardial tissue containing mostly V 3 forms. 29 - 30 Several models of hypertrophy show that the distribution of myosin heavy chain forms shifts from predominantly V, (a-myosin heavy chain) in normal adult myocardium to predominantly V 3 (/3-myosin heavy chain) in hearts that have hypertrophied due to disease. 31 In both renal hypertensive rats 19 and SHR 32 there is an increase in V 3 forms of myosin heavy chain that can be corrected by appropriate antihypertensive therapy.
19
- 32 An increase in /3-myosin heavy chain gene expression has also been observed in the overloaded human heart. 33 Thus, the percentage of myosin heavy chain forms found as V 3 has been considered a biochemical marker for pathological hypertrophy. We observed that cardiac myocytes treated with myotrophin showed a 300% increase in the level of j3-myosin heavy chain transcripts, as well as an increase in the percentage of myosin heavy chain forms found as V 3 .
Another important point to note is that myotrophin treatment did not induce a reciprocal decrease in a-myosin heavy chain transcript levels. The static level of a-myosin heavy chain transcripts associated with increased /3-myosin heavy chain transcript levels is similar to those reported by others 3435 in hearts hypertrophied by pressure overload. Since our ultrastructural data suggested an increase in gap junction formation in cells treated with myotrophin, we examined the effect of myotrophin on the level of connexin 43 transcripts. Myotrophin induced a fourfold increase in the level of connexin 43 transcript level in treated cardiomyocyte.
Myotrophin closely mimics the changes in transcript levels due to pressure overload. Acidic fibroblast growth factor decreases a-myosin heavy chain and skeletal a-actin mRNA levels 36 in contrast to changes seen in hypertrophy due to pressure overload. Both basic fibroblast growth factor and transforming growth factor-/?! downregulate a-myosin heavy chain mRNA levels but show other changes similar to that seen in pressure overload hypertrophy. 36 a,-Adrenergic agonists show changes in transcript levels very similar to that seen in hypertrophy due to pressure overload. 37 -40 It is probable that diverse factors contribute to the growth of differentiated myocytes. Conceivably, a variety of humoral or mechanical stimuli are translated intracellularly into one or more signals for altered gene expression and subsequently cellular function. The factor that we have isolated showed stimulation of myocardial growth, suggesting that this factor plays a role in cell differentiation and hypertrophy. 2 Myotrophin also induced alterations in early response genes that are commonly seen during cellular growth. It also induced a spectrum of gene changes consistent with hypertrophic growth. We propose that myotrophin may be an important factor in regulating myocyte growth. Further studies are necessary to define the mechanism for myotrophin's action on cellular hypertrophy.
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Myotrophin induces early response genes and enhances cardiac gene expression.
